St-Pierre S - Search Results

1

Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types.

Dumont Y, Satoh H, Cadieux A, Taoudi-Benchekroun M, Pheng LH, St-Pierre S, Fournier A, Quirion R. Dumont Y, et al. Eur J Pharmacol. 1993 Jul 6;238(1):37-45. doi: 10.1016/0014-2999(93)90502-9. Eur J Pharmacol. 1993. PMID: 8405081

2

Inhibitory action of neuropeptide Y on agonist-induced responses in isolated guinea pig trachea.

T-Benchekroun M, Fournier A, St-Pierre S, Cadieux A. T-Benchekroun M, et al. Eur J Pharmacol. 1992 Jun 17;216(3):421-8. doi: 10.1016/0014-2999(92)90440-f. Eur J Pharmacol. 1992. PMID: 1385164

3

Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain.

Dumont Y, Fournier A, St-Pierre S, Schwartz TW, Quirion R. Dumont Y, et al. Eur J Pharmacol. 1990 Dec 4;191(3):501-3. doi: 10.1016/0014-2999(90)94189-5. Eur J Pharmacol. 1990. PMID: 1964914 No abstract available.

4

hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.

Dennis T, Fournier A, Cadieux A, Pomerleau F, Jolicoeur FB, St Pierre S, Quirion R. Dennis T, et al. J Pharmacol Exp Ther. 1990 Jul;254(1):123-8. J Pharmacol Exp Ther. 1990. PMID: 2164085

5

Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.

Martel JC, Fournier A, St-Pierre S, Dumont Y, Forest M, Quirion R. Martel JC, et al. Mol Pharmacol. 1990 Oct;38(4):494-502. Mol Pharmacol. 1990. PMID: 2172766

6

Structural study of the N-terminal segment of neuropeptide tyrosine.

Forest M, Martel JC, St-Pierre S, Quirion R, Fournier A. Forest M, et al. J Med Chem. 1990 Jun;33(6):1615-9. doi: 10.1021/jm00168a014. J Med Chem. 1990. PMID: 2342055

7

Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity.

Dennis T, Fournier A, St Pierre S, Quirion R. Dennis T, et al. J Pharmacol Exp Ther. 1989 Nov;251(2):718-25. J Pharmacol Exp Ther. 1989. PMID: 2553933

8

Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.

Dumont Y, Fournier A, St-Pierre S, Quirion R. Dumont Y, et al. J Pharmacol Exp Ther. 1995 Feb;272(2):673-80. J Pharmacol Exp Ther. 1995. PMID: 7853181

9

Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.

Dumont Y, Cadieux A, Pheng LH, Fournier A, St-Pierre S, Quirion R. Dumont Y, et al. Brain Res Mol Brain Res. 1994 Oct;26(1-2):320-4. doi: 10.1016/0169-328x(94)90105-8. Brain Res Mol Brain Res. 1994. PMID: 7854062

10

Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain.

van Rossum D, Ménard DP, Fournier A, St-Pierre S, Quirion R. van Rossum D, et al. J Pharmacol Exp Ther. 1994 Aug;270(2):779-87. J Pharmacol Exp Ther. 1994. PMID: 8071870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters